Samsung Faces Major Strike Threat as Union Restarts Pay Talks 
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026 
Standard Chartered Appoints Manus Costello as New CFO Amid Leadership Reshuffle 
Standard Chartered Targets Higher Profitability With Major Workforce Cuts 
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness 
Warren Buffett and Stephen Curry Charity Dinner Auction Raises $27 Million for Nonprofits 
Anthropic Nears $30 Billion Funding Round at $900 Billion Valuation 
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
Samsung, Union Edge Closer to Deal as Strike Threat Looms 
Elliott Targets Bio-Rad as Shares Continue to Struggle 
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention 
Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates 
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge 
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor 
TSMC Stake Sale Sends Vanguard Semiconductor Shares Lower 
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO 
BURLINGTON, Mass., Sept. 20, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will participate in the 2016 Dougherty & Co. Institutional Investor Conference on Wednesday, September 28, 2016 at the Millennium Hotel in Minneapolis, MN.
For more information or to register, please visit the conference website at www.doughertymarkets.com.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Steven Chehames Investor Relations Coordinator +1-781-425-1659 [email protected] http://www.lemaitre.com
